BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Company News  |  Deals

Invivoscribe, Novartis deal

Invivoscribe and its CLIA-certified Laboratory for Personalized Molecular Medicine (LabPMM) subsidiary partnered with Novartis' Novartis Molecular Diagnostics (MDx) unit to develop and commercialize a companion diagnostic test to...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >